Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04994249 · ClinicalTrials.gov registry record
Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation
A clinical trial of Pain and Pain, Chronic, sponsored by Stanford University.
- Active
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT04994249 is a study of Pain and Pain, Chronic that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 250 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04994249, a study of Pain and Pain, Chronic, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
To identify diagnostic and prognostic biomarker signatures of recovery versus having persisting high-impact chronic pain and functional disability in adults with Chronic Musculoskeletal Pain.
Conditions Studied
Study Locations (1)
California
- Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2022-03-21 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04994249
The ClinicalTrials.gov registry entry for NCT04994249 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (18% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Pain appearing as the primary indexed condition, and to 0 interventions.
NCT04994249 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04994249 about?
NCT04994249 is a clinical study titled "Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation". To identify diagnostic and prognostic biomarker signatures of recovery versus having persisting high-impact chronic pain and functional disability in adults with Chronic Musculoskeletal Pain.
What is the current status of trial NCT04994249?
This trial is currently active not recruiting. The enrollment target is 250 participants. The study started on 2022-03-21. Estimated completion is 2027-12-31.
What conditions does trial NCT04994249 study?
This clinical trial studies the following conditions: Pain, Pain, Chronic, Chronic Musculoskeletal Pain, Joint Pain.
Who is sponsoring clinical trial NCT04994249?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04994249 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
Pain With Dementia
RECRUITING · NA
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Defense and Veterans Center for Integrative Pain Management (DVCIPM) Pain Registry Biobank
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.